Dr. Schmulbach is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1200 El Camino Real
South San Francisco, CA 94080Phone+1 650-742-2000
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1995 - 1998
- Loyola University Medical CenterResidency, Internal Medicine, 1992 - 1995
- Saint Louis University School of MedicineClass of 1992
Certifications & Licensure
- CA State Medical License 1995 - 2026
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 57 citationsRandomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211).Pamela L Kunz, Noah T Graham, Paul J Catalano, Halla S Nimeiri, George A Fisher
Journal of Clinical Oncology. 2023-03-01 - 11 citationsAlloanti-c in a c-positive, JAL-positive patient.Joseph Ong, Phyllis S. Walker, Edmond Schmulbach, Jill R. Storry, Sunitha Vege
Vox Sanguinis. 2009-04-01 - 23 citationsScleroderma Renal Crisis With Minimal Skin Involvement and No Serologic Evidence of Systemic SclerosisEsther A. González, Edmond Schmulbach, Bahar Bastani
American Journal of Kidney Diseases. 1994-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: